Novel Drugs for the Treatment of Tuberculosis
Compounds that increase TB therapy efficacy through a mechanism of action for increased tolerance and decreased therapy duration. Background: One third of the world's population is infected with tuberculosis (TB). In 2014, there were 1.5 million TB related deaths. The current recommended treatment regimen for TB begins with a two-month intensive therapy...
Published: 6/5/2023
|
Inventor(s): Nicole Sampson, Xinxin Yang, Tianao Yuan
Keywords(s):
Category(s): Campus > Stony Brook University, Technology Classifications > Drug Design and/or Synthesis
|